Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma.
Stauffer S, Roth JS, Hernandez ER, Kowalczyk JT, Sealover NE, Hebron KE, James A, Isanogle KA, Riffle LA, Ileva L, Luo X, Chen JQ, Kedei N, Kortum RL, Lei H, Shern JF, Kalen JD, Edmondson EF, Hall MD, Difilippantonio S, Thiele CJ, Yohe ME.
Stauffer S, et al. Among authors: thiele cj.
Cancers (Basel). 2024 Jun 25;16(13):2320. doi: 10.3390/cancers16132320.
Cancers (Basel). 2024.
PMID: 39001383
Free PMC article.